taken
syndr
potentially
1250
address
seropositive
mild
appropriate
rate
ran
hosegood
conditions
outcome
education
friedman
reducing
even
gest
los
final
already
knowledge
anonymised
kimmel
africans
environments
gault
nicastri
aetiology
estimating
americans
2116
2250
kaloustian
references
set
tial
downing
capture
biopsies
sion
franey1
both
targeted
ratios
hbac
collec
recommendation
1289
disease
jones
muloma
sug
sions
age
higher
tests
deci
results
som
late
dk
scarce
extent
tem
four
gfr
1271
yrs
detectable
recommendations
terminology
mdedicoat
individual
imperial
univariably
routine
partnership
calculate
pre
studies
intensive
empangeni
utility
college
understanding
identified
2212
mn
individ
2500
rl
populations
sicker
southern
natal
series
kznhealth
resource
combination
md
holt
investigate
original
nelson
doi
aids
published
tive
widely
chem
retroviruses
mls
barnighausen
ra
saha
under
harder
assounga
263
accessed
disoproxil
toxicity
accepted
urine
medical
records
192
without
department
variates
living
follow
consent
nnrti
back
as
opportunistic
shadows
variables
assessment
child
centre
org
limitations
franceschini
cited
cofac
2009
1909
differ
forward
ts
epidemic
method
any
more
cross
report
september
newell1
1273
uri
validity
neither
fa
fact
seen
drug
only
recorded
kig
sometimes
119
devel
lished
montaner
seven
gm
dependent
screen
roll
cf
associated
obesity
dosages
george
da
041
less
newell
brooks
creati
afri
110
finding
biomedcentral
differing
mr
make
biopsy
august
input
statacorp
leaving
world's
1885
individuals
committee
unrestricted
immunodeficiency
sis
antiretroviral
basis
improve
resources
detected
gazzard
dm
levels
creative
transplant
lower
design
interests
package
gerntholtz
infect
2334
pj
licenses
specificity
ther
impediment
dated
guide
genetic
impairment
choice
doctors
recent
hivan
nephrotixic
1africa
wyatt
sources
dipstick
blacks
meant
cohort
hospital
carafraney
ofovir
costs
ongoing
http
may
different
specificty
adam2
johannesburg
ag
sg
int
number
ea
tbarnighausen
relevance
population
test
biased
how
cockcroft
therefore
having
hamzah
pressure
also
related
pub
analy
like
harvard
haart
antiretrovirals
ml
comparisons
depend
page
logistic
egfr
june
assessed
gargalianos
combining
programme
time
human
complex
has
2007
ken
medica
useful
desperate
medication
sufficiently
143
ozi
retrospective
rodriguez
intercurrent
therapy
haematuria
261
cara
nalysis
facility
observed
collins
herbst
aubrey
yan
particularly
perhaps
pop
glomerular
primary
coded
kipruto
email
inexpensive
targeting
access
urban
setting
thank
dine
note
nature
there
western
race
roviral
varying
roland
authors
lessells
hendry
african
should
discus
he
clinical
properly
additional
assumption
improves
fisher
africacentre
cooper
findings
suggesting
per
performed
whereas
sensitive
important
175
zilmer
comparison
all
thy
dipsticks
factor
including
mmhg
itself
df
bm
batzing
black
create
below
mod
cases
reid
methods
deborah
details
significant
confidently
han
impaired
post
2119
hotmail
dicted
1adjusted
suggest
wski
alternative
protein
242
ethnicity
martin
weidle
hughes
kt
national
care
permits
estimations
study
yahoo
2189
untreated
about
defined
jp
shen
formed
200
monitoring
competing
gilks
glucose
996
moore
ease
large
proceed
cooke
bles
subtype
mocroft
treatment
kwazulu
reductions
category
central
316
tion
adam
varia
baseline
menstruating
campbell
2005
america
furthermore
reported
recruited
demographic
it's
whether
was
assess
countries
identification
half
progression
available
welz
however
patients
find
laboratory
among
ies
palella
approval
te
abbreviated
lj
will
infected
cohorts
nonetheless
numbers
dedicated
tashima
direct
blood
increased
frequent
six
287
thus
similar
consecutive
nevirapine
3901
license
explanation
1559
larger
tool
here
167
raised
given
separate
article
serum
clin
female
acute
offer
roe
publication
www
ysis
diseases
programmes
characteristics
geneva
single
ing
239
limited
within
obtained
alteration
tubular
ble
bmc
infections
management
ulation
equal
ig
itive
used
when
responsible
background
ground
necrosis
incidence
perazella
ii
initiating
schewe
originating
causes
stavu
1062
point
dysfunction
williams
rw
small
tor
reading
training
nearly
low
through
modification
purposes
pl
tions
introducing
gatell
lucas
sj
either
detect
review
1281
values
interpreted
bugu
efavirenz
closer
germany
specialist
size
estimates
lines
doses
safety
goetsch
chance
knott
majority
barnighausen1
existing
ethical
intro
us
reproduction
cannot
along
hiv
severe
reduced
jd
feared
barrier
sub
2003
categorical
medicine
shown
excluded
contribute
contributions
unaids
6division
interesting
biochemistry
1068
boydstun
matter
1585
dence
importance
people
sensitivity
tanser
nephropathy
local
whom
reiss
sensi
ltd
eligible
lazzarin
outpatient
buchacz
nephropa
inform
diagnosed
approximately
fj
sd
uncommon
continues
table
green
real
ously
or
could
research
ja
ucl
dbbknott
cd4
licensee
stohr
male
prior
mdrd
would
significantly
doing
global
kenya
kidney
planning
hypertension
anal
approach
sk
aor
ticipants
district
van
lence
bhagani
imply
tb
tk
undergo
who
simple
149
hill
failure
factors
aor1
calculation
multistix
lundgren
ortiz
kirk
many
lange
author
benio
initiated
wools
representative
gupta
patient
1202
programmatic
presented
possibility
alone
ated
little
ahuja
cents
combina
beyond
fumarate
erate
possible
antiret
marie
cost
features
its
ppv
typically
group
ducing
classified
particular
than
effective
urinalysis
richard
cells
stud
lessells1
underlying
bio
following
gcooke
data
hum
mermin
takes
medications
new
respectively
needed
1891
jt
min
itoring
prospective
conclusion
start
variable
preva
acquired
predictors
katz
naicker
ten
groups
regarding
be
detailed
most
had
information
chronic
delivered
236
means
biomed
sustained
advanced
west
capillary
uganda
increasing
degrees
analysis
demographics
paper
received
availa
2243
mg
cohen
adults
viral
applied
function
graham
financial
biases
non
validating
hiding
society
missing
infectious
mugyenyi
likely
positive
com
249
siwani
saharan
bourgoignie
ugandans
american
nephrol
involved
other
623
university
another
deventer
2008
ticularly
1119
descent
inadequate
sex
well
office
chemistry
potential
hlabisa
gender
156
world
additionally
1989
val
differed
atta
terms
kam
regard
uals
lamivudine
100
prioritising
their
best
included
required
distribution
but
over
prevent
citation
ibrahim
receive
unlikely
evidence
easy
coming
vali
tenofovir
based
dial
rural
peters
made
filtration
field
transplantation
estimation
greater
such
zulu
ment
khele
immunosuppression
routinely
nine
pk
represent
reason
gc
healthcare
contributed
franey
identifying
use
feigenbaum
despite
viard
johnson
conference
whilst
establish
texas
complication
began
interpreta
3899
medium
perspective
abstract
acknowledgements
ramdial
above
combined
dipstix
symptomatic
tine
127
studied
presence
circulating
regardless
south
dis
1197
few
bayer
stata10
fine
poor
treatments
think
known
differences
rou
line
helpful
stated
gov
investigations
need
centres
outside
validated
collecting
trials
ij
program
period
although
pered
2006
js
ences
4ngwelezane
mj
pathology
1282
impair
tens
during
accessing
recently
distributed
2hlabisa
1186
attribution
open
height
mnewell
ulations
they
diagnosis
popula
aa
becker
according
options
je
antiretro
date
median
month
model
appears
ma
confi
addition
risk
sidle
poorly
similarly
dedicoat4
120
1987
continuous
adoles
161
ong'or
5institute
random
run
mon
predictive
prevalence
zwickl
measurements
detection
home
provided
relatively
rlessells
types
naive
commons
determine
become
diet
history
ahmed
caution
record
might
knott2
roth
treat
whose
par
corresponding
recruit
teinuria
discussion
started
moderate
dedicoat
defic
counts
dys
clotet
work
service
pro
settings
two
count
abbrevi
africa
multivariable
weight
suggests
ticular
approved
detecting
valuable
one
estimated
usa
kityo
nega
proportion
reasons
tm
684
hyper
network
ings
sample
very
infection
odds
walker
equations
999
3school
pos
locally
journal
ratio
till
staszewski
wards
1471
goldman
facilities
ci
due
regression
collected
often
reflect
creativecommons
changes
areas
described
bsa
allow
others
estimat
renal
sector
acquir
proteinuria
aged
munderi
ipants
ad
partic
between
jj
dose
1127
winston
angeles
public
england
illness
using
hivick
mildly
ethics
siedner
diabetes
ever
initiation
manuscript
organised
declare
2004
stavudine
uk
sectional
previ
guidelines
slightly
surprising
ugandan
nor
categorised
exists
diastolic
kwa
apy
further
november
oped
possi
ues
diagnostic
therapeutic
found
association
2208
iqr
eustace
across
poten
clear
interian
louise
screening
paiker
read
once
present
iv
katlama
creatinine
version
common
health
out
stage
hospitalised
strategies
moderately
correction
owino
require
starting
1505
immune
syndrome
not
years
informed
rao
services
before
high
availability
first
structure